<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0002204'>Pulmonary embolism</z:hpo> is thought to be associated with a small but definite risk of <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">paradoxical embolism</z:e> in patients with a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>Although neurological complications are infrequent, the incidence of clinically silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed the rate of clinically apparent and silent <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> in patients with <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> in relation to the presence or not of a <z:mp ids='MP_0004225'>PFO</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We used diffusion-weighted MRI in patients hospitalized for a <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> to assess cerebral embolic events </plain></SENT>
<SENT sid="4" pm="."><plain>Sixty consecutive patients were evaluated at diffusion-weighted MRI </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent neurological assessment before diffusion-weighted MRI and a contrast echocardiography to detect <z:mp ids='MP_0004225'>PFO</z:mp> the next day </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Diffusion-weighted MRI showed bright lesions in 6 patients among the 60 consecutive patients with <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> in a pattern consistent with embolic events </plain></SENT>
<SENT sid="7" pm="."><plain>There was only one patient with a neurological deficit </plain></SENT>
<SENT sid="8" pm="."><plain>After contrast echocardiography, a <z:mp ids='MP_0004225'>PFO</z:mp> was diagnosed in 15 patients (25%) </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> in patients with a <z:mp ids='MP_0004225'>PFO</z:mp> was significantly higher than in patients without <z:mp ids='MP_0004225'>PFO</z:mp> (5 [33.3%] of 15 versus one [2.2%] of 45 patients, P=0.003) </plain></SENT>
<SENT sid="10" pm="."><plain>By logistic regression analysis, <z:mp ids='MP_0004225'>PFO</z:mp> was identified as an independent predictor of silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> (OR, 34.9 [3.1 to 394.3]; P=0.004) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, cerebral embolic events are more frequent than the apparent neurological complication rate </plain></SENT>
<SENT sid="12" pm="."><plain>The prevalence of silent brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> is closely related to the presence of a <z:mp ids='MP_0004225'>PFO</z:mp> suggesting a high incidence of unsuspected paradoxical emboli in those patients </plain></SENT>
</text></document>